News

Truist analysts raised their price target on Amazon (NASDAQ:AMZN) shares to $250 from $226 in a note Wednesday, maintaining a ...
Investing.com -- Bernstein analysts remain bullish on Starbucks (NASDAQ: SBUX ), stating the stock could double from its post ...
Investing.com -- Regeneron Pharmaceuticals (NASDAQ: REGN) stock rose 2.8% after the U.S. Food and Drug Administration granted accelerated approval for the company’s blood cancer therapy Lynozyfic.